Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
Top Cited Papers
- 15 December 2010
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 2 (62), 62ra93
- https://doi.org/10.1126/scitranslmed.3001451
Abstract
FGFR1 amplification provides a therapeutic target for squamous cell lung cancer, which is resistant to other targeted lung cancer drugs.This publication has 33 references indexed in Scilit:
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerThe New England Journal of Medicine, 2010
- A Structure-Guided Approach to Creating Covalent FGFR InhibitorsCell Chemical Biology, 2010
- FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast CancerCancer Research, 2010
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- Fibroblast growth factor signalling: from development to cancerNature Reviews Cancer, 2010
- Chemogenomic Profiling Provides Insights into the Limited Activity of Irreversible EGFR Inhibitors in Tumor Cells Expressing the T790M EGFR Resistance MutationCancer Research, 2010
- Amplification of chromosomal segment 4q12 in non-small cell lung cancerCancer Biology & Therapy, 2009
- Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorJournal of Clinical Oncology, 2003
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2The New England Journal of Medicine, 2001
- Effect of cigarette smoking on major histological types of lung cancer: a meta-analysisLung Cancer, 2001